92 related articles for article (PubMed ID: 10790730)
1. For ischemic brain damage, is preclinical evidence of neuroprotection by presynaptic blockade of glutamate release enough?
Nava-Ocampo AA; Reyes-Pérez H; Bello-Ramírez AM; Mansilla-Olivares A; Ponce-Monter H
Med Hypotheses; 2000 Jan; 54(1):77-9. PubMed ID: 10790730
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
[TBL] [Abstract][Full Text] [Related]
3. Targets of cytoprotection in acute ischemic stroke: present and future.
Lizasoain I; Cárdenas A; Hurtado O; Romera C; Mallolas J; Lorenzo P; Castillo J; Moro MA
Cerebrovasc Dis; 2006; 21 Suppl 2():1-8. PubMed ID: 16651809
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of the neuroprotective effects of thiopental sodium, propofol, and halothane on brain ischemia in the gerbil: effects of the anesthetics on ischemic depolarization and extracellular glutamate concentration.
Kobayashi M; Takeda Y; Taninishi H; Takata K; Aoe H; Morita K
J Neurosurg Anesthesiol; 2007 Jul; 19(3):171-8. PubMed ID: 17592348
[TBL] [Abstract][Full Text] [Related]
5. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia.
Calabresi P; Cupini LM; Centonze D; Pisani F; Bernardi G
Ann Neurol; 2003 Jun; 53(6):693-702. PubMed ID: 12783414
[TBL] [Abstract][Full Text] [Related]
6. Glutamate efflux from human cerebrocortical slices during ischemia: vesicular-like mode of glutamate release and sensitivity to A(2A) adenosine receptor blockade.
Marcoli M; Bonfanti A; Roccatagliata P; Chiaramonte G; Ongini E; Raiteri M; Maura G
Neuropharmacology; 2004 Nov; 47(6):884-91. PubMed ID: 15527822
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.
Pérez-Asensio FJ; Hurtado O; Burguete MC; Moro MA; Salom JB; Lizasoain I; Torregrosa G; Leza JC; Alborch E; Castillo J; Knowles RG; Lorenzo P
Neurobiol Dis; 2005 Mar; 18(2):375-84. PubMed ID: 15686966
[TBL] [Abstract][Full Text] [Related]
8. Ischemic preconditioning ameliorates excitotoxicity by shifting glutamate/gamma-aminobutyric acid release and biosynthesis.
Dave KR; Lange-Asschenfeldt C; Raval AP; Prado R; Busto R; Saul I; Pérez-Pinzón MA
J Neurosci Res; 2005 Dec; 82(5):665-73. PubMed ID: 16247804
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels.
Xiong ZG; Zhu XM; Chu XP; Minami M; Hey J; Wei WL; MacDonald JF; Wemmie JA; Price MP; Welsh MJ; Simon RP
Cell; 2004 Sep; 118(6):687-98. PubMed ID: 15369669
[TBL] [Abstract][Full Text] [Related]
10. [Neuroprotection by aspirin in cerebrovascular pathology].
Lorenzo Fernández P
An R Acad Nac Med (Madr); 2002; 119(2):311-20; discussion 320-6. PubMed ID: 12518657
[TBL] [Abstract][Full Text] [Related]
11. Effects of isoflurane on glutamate and taurine releases, brain swelling and injury during transient ischemia and reperfusion.
Ritz MF; Schmidt P; Mendelowitsch A
Int J Neurosci; 2006 Feb; 116(2):191-202. PubMed ID: 16393884
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of emodin-8-O-beta-D-glucoside in vivo and in vitro.
Wang C; Zhang D; Ma H; Liu J
Eur J Pharmacol; 2007 Dec; 577(1-3):58-63. PubMed ID: 17897641
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies.
Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K
Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: role of glutamate uptake and FK506 binding protein 12 kDa.
Labrande C; Velly L; Canolle B; Guillet B; Masmejean F; Nieoullon A; Pisano P
Neuroscience; 2006; 137(1):231-9. PubMed ID: 16289353
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reuptake.
Colleoni S; Jensen AA; Landucci E; Fumagalli E; Conti P; Pinto A; De Amici M; Pellegrini-Giampietro DE; De Micheli C; Mennini T; Gobbi M
J Pharmacol Exp Ther; 2008 Aug; 326(2):646-56. PubMed ID: 18451317
[TBL] [Abstract][Full Text] [Related]
16. Enhanced activity of GABA receptors inhibits glutamate release induced by focal cerebral ischemia in rat striatum.
Ouyang C; Guo L; Lu Q; Xu X; Wang H
Neurosci Lett; 2007 Jun; 420(2):174-8. PubMed ID: 17531382
[TBL] [Abstract][Full Text] [Related]
17. Effects of nicotine infusion on striatal glutamate and cortical non-protein-bound iron in hypoxic newborn piglets.
Andresen JH; Saugstad OD
Neonatology; 2008; 94(4):284-92. PubMed ID: 18784425
[TBL] [Abstract][Full Text] [Related]
18. Pre-ischemic treadmill training affects glutamate and gamma aminobutyric acid levels in the striatal dialysate of a rat model of cerebral ischemia.
Jia J; Hu YS; Wu Y; Liu G; Yu HX; Zheng QP; Zhu DN; Xia CM; Cao ZJ
Life Sci; 2009 Apr; 84(15-16):505-11. PubMed ID: 19302809
[TBL] [Abstract][Full Text] [Related]
19. Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission.
Battaglia G; Bruno V; Pisani A; Centonze D; Catania MV; Calabresi P; Nicoletti F
Mol Cell Neurosci; 2001 Jun; 17(6):1071-83. PubMed ID: 11414795
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes).
Wang SJ; Wang KY; Wang WC
Neuroscience; 2004; 125(1):191-201. PubMed ID: 15051158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
